EMILY CRABTREE, FNP-C
Registered Nurse in ABINGDON, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
EMILY CRABTREE, FNP-C filed 9,359 Medicare Part D claims in 2023 as a Registered Nurse in ABINGDON, Virginia, prescribing 87% generic.
- 9K
- Part D claims, 2023
- 87%
- generic prescribing
- $1.2K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
EMILY CRABTREE, FNP-C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
9,359 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about EMILY CRABTREE, FNP-C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Virginia
How Registered Nurse compares to other specialties among Virginia providers
Registered Nurse share within Virginia
Registered Nurse is one of the more visible NUCC categories in Virginia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Registered Nurse (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Registered Nurse ABMS/AOA estimate
Est. board-certified rate (Registered Nurse) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Registered Nurse US NPIs
Specialty board-certified rate — Registered Nurse estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
EMILY CRABTREE, FNP-C appears in the CMS NPPES registry as a Registered Nurse provider holding FNP-C credentials at 24530 FALCON PLACE BLVD STE 100, ABINGDON, VA, 24211, with a listed phone of (276) 619-0075. NPI 1639525975 was issued on 05/05/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CRABTREE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 9,359 prescription claims written by this provider, covering 411 Medicare beneficiaries and totaling roughly $931K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 5.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Registered Nurse is a high-volume specialty nationwide, with 175,652 enrolled providers across 56 states and an average of 1,000 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1639525975 |
|---|---|
| Specialty | Registered Nurse |
| Credentials | FNP-C |
| Gender | Female |
| NPI Issued | 05/05/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm EMILY CRABTREE, FNP-C's current license status, disciplinary history, and board certifications with the Virginia Board of Medicine in Virginia before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where EMILY CRABTREE, FNP-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EMILY CRABTREE, FNP-C. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 9,359 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 17,367
- Total Day Supply
- 501,362
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $759K
- Generic Drug Cost
- $167K
- Opioid Claims
- 487 (5.2% rate)
- Antibiotic Claims
- 272
Patient Demographics
- Average Patient Age
- 68.5 years
- Avg HCC Risk Score
- 1.42
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 112, 65-74: 177, 75-84: 94, 85+: 28
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What EMILY CRABTREE, FNP-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
384 claims
- Lisinopril
Lisinopril
294 claims
- Levothyroxine Sodium
Levothyroxine Sodium
263 claims
- Omeprazole
Omeprazole
243 claims
- Atorvastatin Calcium
Atorvastatin Calcium
239 claims
- Montelukast Sodium
Montelukast Sodium
235 claims
- Amlodipine Besylate
Amlodipine Besylate
211 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
195 claims
| Drug | Claims |
|---|---|
| Gabapentin | 384 |
| Lisinopril | 294 |
| Levothyroxine Sodium | 263 |
| Omeprazole | 243 |
| Atorvastatin Calcium | 239 |
| Montelukast Sodium | 235 |
| Amlodipine Besylate | 211 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 195 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 194 |
| Tizanidine Hcl | 185 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Registered Nurse Overview
How EMILY CRABTREE, FNP-C fits within the Registered Nurse landscape nationally.
EMILY CRABTREE, FNP-C's 9,359 claims are above the specialty average of 1,000.
Nearby Registered Nurse Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as CRABTREE.
Compare Registered Nurse nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Virginia
Frequently Asked Questions
What is EMILY CRABTREE, FNP-C's specialty? ▼
How much does EMILY CRABTREE, FNP-C prescribe under Medicare Part D? ▼
Where is EMILY CRABTREE, FNP-C located? ▼
What is EMILY CRABTREE, FNP-C's NPI number? ▼
Does EMILY CRABTREE, FNP-C prescribe more brand-name or generic drugs? ▼
Does EMILY CRABTREE, FNP-C prescribe opioids? ▼
How many Registered Nurse providers are there in the US? ▼
What drugs does EMILY CRABTREE, FNP-C prescribe most often? ▼
Does EMILY CRABTREE, FNP-C accept Medicare? ▼
How can I verify EMILY CRABTREE, FNP-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology